ESTRELLA Trademark

Trademark Overview

On Wednesday, June 23, 2021, a trademark application was filed for ESTRELLA with the United States Patent and Trademark Office. The USPTO has given the ESTRELLA trademark a serial number of 90789820. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The ESTRELLA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

General Information

Serial Number90789820
Word MarkESTRELLA
Filing DateWednesday, June 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Translation of Words in MarkThe English translation of "ESTRELLA" in the mark is "STAR."
Goods and ServicesPharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Saturday, June 26, 2021NEW APPLICATION ENTERED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2021ASSIGNED TO EXAMINER
Thursday, December 16, 2021NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021NON-FINAL ACTION E-MAILED
Thursday, December 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 17, 2022SOU EXTENSION 1 FILED
Thursday, November 17, 2022SOU EXTENSION 1 GRANTED
Saturday, November 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 2 FILED
Monday, May 15, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

estrella pharmaceuticals field research scientific information trials medical clinical testing development